Pfizer-BioNTech to Test COVID Vaccine in Pregnant Women By Rachel Tillman Nationwide
SHARE
Pfizer-BioNTech announced on Thursday that it is set to begin a global study testing the efficacy of its coronavirus vaccine in pregnant women over the age of 18.
What You Need To Know
Pfizer-BioNTech is set to begin a global study testing its COVID vaccine in healthy pregnant women over the age of 18
Women will receive their first shot between 24 and 34 weeks of gestation, with the total length of the study lasting approximately 7 to 10 months
Doctors also plan to study the participants’ children for up to six months after they give birth